High Level of Serum Cholesteryl Ester Transfer Protein and Chemerin as a Risk Factor of Metabolic Syndrome in Adolescent Obese and the Description of Cholesteryl Ester Transfer Protein −629c/A Gene Promoter Polymorphism

I. Made Arimbawa; Ketut Suastika; Ketut Junitha; I. Wayan Bikin Suryawan; Michelle Husin

doi:10.3889/oamjms.2020.4655

Authors

I. Made Arimbawa Department of Child Health, Sanglah General Hospital, Faculty of Medicine, Udayana University, Denpasar, Indonesia
Ketut Suastika Department of Internal Medicine, Sanglah General Hospital, Faculty of Medicine, Udayana University, Denpasar, Indonesia
Ketut Junitha Department of Biology, Faculty of Mathematic and Natural Sciences, Udayana University, Denpasar, Indonesia
I. Wayan Bikin Suryawan Department of Child Health, Wangaya General Hospital, Denpasar, Indonesia
Michelle Husin Department of Child Health, Sanglah General Hospital, Faculty of Medicine, Udayana University, Denpasar, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.4655

Keywords:

metabolic syndrome, CETP-629C/A gene promotor polymorphism, high of CETP serum, chemerin levels, obese adolescent

Abstract

BACKGROUND: The prevalence of metabolic syndrome (MS) in children and adolescents has increased, along with increasing incidence of obesity.

AIM: The aim of this study was to find out the polymorphism characteristic of cholesteryl ester transfer protein (CETP) -629C/A gene promoter and to prove that the CETP -629C/A polymorphism, serum CETP, and chemerin levels were risk factors of MS in obese adolescents.

MATERIALS AND METHODS: A matched case–control study with obese adolescent aged 11–18 years was conducted from May to December 2017. Samples were consecutively recruited in seven junior and senior high schools in Denpasar. Case groups were obese adolescents with MS and control groups were obese adolescents without MS (non-MS obese). Both groups fulfilled eligibility criteria were matched by gender and puberty status. The study data were analyzed by Chi-square test and logistic regression with significant level p < 0.05.

RESULTS: Analysis of CETP -629C/A polymorphism showed, AA and CA genotype were not a risk factors for MS when compared with CC genotype (OR = 0.81 [95% CI 0.23–2.88], p = 0.75 and OR = 0.95 [95% CI 0.38–2.37] p = 0.91, respectively). There was no significant difference between individual carriers A allele with individual carriers C allele to risk of MS (OR = 0.91 [95% CI 0.39–2.14], p = 0.83). The cutoff point of CETP levels was ≥2 μg/mL considered as CETP high levels, and <2 μg/mL considered normal; chemerin levels ≥170 ηg/mL considered as chemerin high levels, and <170 ηg/mL considered as normal. High levels of serum CETP were a risk factor in MS compared to normal levels (OR = 2.82 [95% CI 1.07–7.41], p = 0.036) and high levels of serum chemerin were a risk factor in MS compared to normal level (OR = 2.77 [95% CI 1.04–7.40], p = 0.042).

CONCLUSION: This study concluded that high levels of serum CETP and chemerin were the risk factors for MS, while genotype AA CETP -629C/A gene polymorphism was not a risk factor for MS.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011- 2012. JAMA. 2014;311(8):806-14. https://doi.org/10.1001/ jama.2014.732 PMid:24570244

Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307(5):483-90. https:// doi.org/10.1001/jama.2012.40 PMid:22253364

Kementerian Kesehatan RI. Riset Kesehatan Dasar (Riskesdas) Tahun 2013. Indonesia: Kementerian Kesehatan RI; 2013.

Adhianto G, Soetjiningsih S. Prevalence and risk factors of overweight and obesity in adolescent. Paediatr Indones. 2002;42(9-10):206-11.

Dewi MR, Sidiartha GL. Prevalensi dan faktor risiko obesitas anak sekolah dasar di daerah urban dan rural. Medicina. 2013;44:15-21. https://doi.org/10.14710/jgi.6.2.90-93

Costa RF, Santos NS, Goldraich NP, Barski TF, Andrade KS, dan Kruel LF. Metabolic syndrome in obese adolescents: A comparison of three different diagnostic criteria. J Pediatr (Rio J). 2012;88(4):303-9. https://doi.org/10.2223/jped.2200

PMid:22622762

Pulungan AB, Puspitadewi A, Sekartini R. Prevalence of insulin resistance in obese adolescents. Paediatr Indones. 2013;53(3):167-72. https://doi.org/10.14238/pi53.3.2013.08

Dwipayana MP, Suastika K, Saraswati IM, Gotera W, Budhiarta AA, Sutanegara MD, et al. Prevalensi sindroma metabolik pada populasi penduduk bali, Indonesia. J Penyakit Dalam. 2011;12:1-12.

Carty CL, Bhattacharjee S, Haessler J, Cheng I, Hindorff LA, Aroda V, et al. Analysis of metabolic syndrome components in >15000 African Americans identifies pleiotropic variants: Results from the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet. 2014;7(4):505-13. https://doi.org/10.1161/circgenetics.113.000386 PMid:25023634

Zhang L, Yan F, Zhang S, Lei D, Charles MA, Cavigiolio G, et al. Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Nat Chem Biol. 2012;8(4):342-9. https:// doi.org/10.1038/nchembio.796 PMid:22344176

Kwiterovich PO Jr. The metabolic pathways of high-density lipoprotein,low-density lipoprotein, and triglycerides: A current review. Am J Cardiol. 2000;86(12):5L-10. https://doi. org/10.1016/s0002-9149(00)01461-2 PMid:11374859

Masson D, Jiang XC, Lagrost L, dan Tall AR. The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. J Lipid Res. 2009;50:S201-6. https://doi. org/10.1194/jlr.r800061-jlr200 PMid:19023137

Chirasani VR, Revanasiddappa PD, dan Senapati S. Structural plasticity of cholesteryl ester transfer protein assists the lipid transfer activity. J Biol Chem. 2016;291(37):19462-73. https:// doi.org/10.1074/jbc.m116.744623 PMid:27445332

Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, et al. Specific recruitment of antigenpresenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003;198(7):977-85. https://doi.org/10.1084/ jem.20030382 PMid:14530373

Mattern A, Zellmann T, Beck-Sickinger AG. Processing, signaling, and physiological function of chemerin. IUBMB Life. 2014;66(1):19-26. https://doi.org/10.1002/iub.1242 PMid:24446308

Goralski KB, McCarthy TC, Hanniman E, Zabel BA, Butcher EC, Parlee SD, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007;282(38):28175-88. https://doi.org/10.1074/jbc. m700793200 PMid:17635925

Li Y, Shi B, Li S. Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: A meta-analysis. PLoS One. 2014;9(12):e113915. https://doi.org/10.1371/journal.pone.0113915 PMid:25469985

Reinehr T. Metabolic syndrome in children and adolescents: A critical approach considering the interaction between pubertal stage and insulin resistance. Curr Diab Rep. 2016;16(1):1-9. https://doi.org/10.1007/s11892-015-0695-1 PMid:26747052

Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol. 2008;159(1):S67-74. https://doi. org/10.1530/eje-08-0245 PMid:18805916

Beigh SH, Jain S. Prevalence of metabolic syndrome and gender differences. Bioinformation. 2012;8(13):613-6. https:// doi.org/10.6026/97320630008613 PMid:22829741

Hou H, Ma R, Guo H, He J, Hu Y, Mu L, et al. Association between six CETP polymorphisms and metabolic syndrome in uyghur adults from Xinjiang, China. Int J Environ Res Public Health. 2017;14(6):653. https://doi.org/10.3390/ijerph14060653 PMid:28629169

Dachet C, Poirier O, Cambien F, Chapman J, dan Rouis M. New functional promotor polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: Role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol. 2000;20(2):507-15. https://doi.org/10.1161/01.atv.20.2.507 PMid:10669650

Maroufi NF, Farzaneh K, Alibabrdel M, Zarei L, Cheraghi O, Soltani S, et al. Taq1B polymorphism of cholesteryl ester transfer protein (CETP) and its effects on the serum lipid levels in metabolic syndrome patients. Biochem Genet. 2016;54(6):894- 902. https://doi.org/10.1007/s10528-016-9766-5 PMid:27496123

Thompson JF, Lira ME, Durham LK, Clark RW, Bamberger MJ, Milos PM. Polymorphisms in the CETP gene and association with CETP mass and HDL levels. Atherosclerosis. 2003;167(2):195- 204. https://doi.org/10.1016/s0021-9150(03)00005-4

Sandhofer A, Kaser S, Ritsch A, Laimer M, Engl J, Paulweber B, et al. Cholesteryl ester transfer protein in metabolic syndrome. Obesity (Silver Spring). 2006;14(5):812-8. https://doi. org/10.1038/oby.2006.94 PMid:16855190

Zanganeh SH, Roostaei F, Shafiepour MR, Mahmoodi M, Khoshdel A, dan Hajizadeh MR. Assessment of serum chemerin level in an Iranian population with metabolic syndrome and healthy individuals in 2016. JOHE. 2016;5(1):38-44.

Yan Q, Zhang Y, Hong J, Gu W, Dai M, Shi J, et al. The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine. 2012;41(2):281-8. https:// doi.org/10.1007/s12020-011-9550-6

Rourke JL, Dranse HJ, Sinal CJ. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes Rev. 2013;14(3):245-62. https://doi. org/10.1111/obr.12009 PMid:23216632

Lu H, Inazu A, Moriyama Y, Higashikata T, Kawashiri MA, Yu W, et al. Haplotype analyses of cholesteryl ester transfer protein gene promoter: A clue to an unsolved mystery of TaqIB polymorphism. J Mol Med (Berl). 2003;81(4):246-55. https://doi. org/10.1007/s00109-002-0414-7 PMid:12700892